Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 30;39(6):e693.
doi: 10.5001/omj.2024.113. eCollection 2024 Nov.

Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection: A Retrospective Study

Affiliations

Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection: A Retrospective Study

Halima H Al-Shuaili et al. Oman Med J. .

Abstract

Objectives: Hepatic fibrosis remains a potential complication for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B virus (HBV) infection. The affected individuals, known as inactive HBV carriers, tend to have a favorable prognosis. This study aimed to determine the prevalence of significant fibrosis and associated risk factors among Omani patients diagnosed as inactive HBV carriers.

Methods: A retrospective study was conducted on Omani inactive HBV carriers visiting a tertiary hospital in Muscat, Oman, between January 2017 and December 2018. Significant hepatic fibrosis (stage F2 or higher) was identified using two-dimensional shear-wave elastography, with baseline clinical, laboratory, and radiological data analyzed for associations.

Results: Among the selected 200 participants (mean age = 44.6 ± 9.3 years), 53.0% were male. Significant fibrosis was present in 40 (20.0%) patients, with a preponderance of male (p =0.007) and those aged ≥ 60 years (p =0.024). Fatty changes, as detected by liver ultrasound, were independent risk factors (p =0.044).

Conclusions: The findings underscore the importance of periodic assessment and monitoring of inactive HBV carriers in Oman, particularly those with risk factors for fibrosis progression, such as male sex, older age, and fatty liver. Non-invasive tests can aid in early detection and management of fibrosis, thereby improving patient outcomes.

Keywords: Hepatic Fibrosis; Inactive Hepatitis B Virus Carriers; Oman; Prevalence; Risk Factors.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram of the study population.
Figure 2
Figure 2
Fibrosis staging among Omani patients with hepatitis B e antigen-negative chronic hepatitis B virus infection (N = 200).
Figure 3
Figure 3
Associations between significant hepatic fibrosis* and (a) sex (p < 0.001), (b) age (p = 0.003), and (c) fatty liver disease (p = 0.049) among Omani patients with HBeAg-negative CHB infection (N = 200).

Similar articles

References

    1. Gao Y, Wang M, Liu X. Noninvasive serum markers for predicting significant liver histopathology in HBeAg-negative chronic HBV-infected patients with normal alanine aminotransferase. Microbiol Spectr 2024. Apr;12(4):e0394123. 10.1128/spectrum.03941-23 - DOI - PMC - PubMed
    1. GBD 2019 Hepatitis B Collaborators . Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol 2022. Sep;7(9):796-829. 10.1016/S2468-1253(22)00124-8 - DOI - PMC - PubMed
    1. Polaris Observatory Collaborators . Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol 2023. Oct;8(10):879-907. 10.1016/S2468-1253(23)00197-8 - DOI - PubMed
    1. McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology 2009. May;49(5)(Suppl):S45-S55. 10.1002/hep.22898 - DOI - PubMed
    1. Sharma SK, Saini N, Chwla Y. Hepatitis B virus: inactive carriers. Virol J 2005. Sep;2:82. 10.1186/1743-422X-2-82 - DOI - PMC - PubMed

LinkOut - more resources